期刊文献+

股动脉介入药物灌注术治疗糖尿病足近期及中期疗效观察

Evaluation of short-and mid-term efficacy of femoral artery intervention in treating diabetic foot
下载PDF
导出
摘要 目的:观察股动脉介入药物灌注术治疗糖尿病足的近期及中期疗效。方法:70例糖尿病足患者,随机分为传统治疗组和介入治疗组,比较治疗前和治疗1周和6个月后下肢麻、冷、痛的情况及踝肱指数(ABI)、浅感觉震动阈值(VPT)变化。结果:治疗1周和6个月后,介入治疗组下肢麻、冷、痛缓解率高于对照组,治疗1周后两组ABI、VPT与治疗前比较,差异有统计学意义(P<0.05)。治疗6月后,介入治疗组ABI、VPT与治疗前比较,差异有统计学意义(P<0.05)。结论:股动脉介入药物灌注术治疗糖尿病足的近期及中期疗效良好。 Objective: To observe the short-and mid-term efficacy of interventional therapy through femoral artery in treating diabetic foot. Methods: 70 cases patients with diabetic foot were divided into two groups. The control group was treated with traditional comprehensive treatment, while the interventional group with combination of traditional comprehensive treatment and interventional therapy. Before and after treatment, we observed the changes of lower limb symptom (numbness, cold and pain), ankle brachial index (ABI) and vibration perception threshold (VPT). Results: 1 week and 6 months after treatment, the remission rate of lower limb symptom (numbness, cold and pain) in the interventional group was significantly higher than the control group (P〈0.05). For the two groups, at week 1 after treatment, ABI significantly increased and VPT significantly decreased, especially in the intervention group (P〈0. 05). However, 6 months after treatment, only the interventional group was found increased ABI and decreased VPT (P〈0.05). Conclusion: The interventional therapy for diabetic foot has better short- and mid-term effect than traditional comprehensive treatment.
出处 《华夏医学》 CAS 2013年第4期686-688,共3页 Acta Medicinae Sinica
关键词 药物灌注术 糖尿病足 疗效 interventional therapy diabetic foot curative effect
  • 相关文献

参考文献5

二级参考文献20

  • 1高华,胡建国,张卓,李剑欣,盛杰,刘锋,李强翔.维生素C保护糖尿病大鼠主动脉的作用机制[J].天津医药,2007,35(2):121-123. 被引量:1
  • 2袁小燕,任跃忠.抗氧化剂治疗糖尿病及其并发症新进展[J].国外医学(老年医学分册),2007,28(2):49-55. 被引量:3
  • 3Schmeichel AM , Schmelzer JD , Low PA . Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy [ J ]. Diabetes, 2003 ;52:165 - 171
  • 4Brownlee M. Biochemistry and molecular cell biology of diabetic complications [J]. Nature, 2001,414:813 - 820
  • 5Packer L, Witt EH, Tritschler HJ. α- Lipoic acid as a biological antioxidant [ J ]. Free Radic Biol Med, 1995,19:227 - 250
  • 6Chowienczyk P, Brett S, Gopaul N , et al. Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with Type 2 diabetes[J]. Diabetologia, 2000,43:974- 977
  • 7Robertson RP,Harmon J, Tran PO,et al. Glucose toxicity in β2cells:type 2 diabetes,good radicals gone bad , and the glutathione connection [ J ]. Diabetes, 2003,82:581 - 587
  • 8Biewenga GP , Haenen GR , Bast A. The pharmacology of the antioxidant lipoic acid[J]. Gen Pharmacol, 1997,29:315 - 331
  • 9Eason SL,Peterson NJ.Diabetes Mellitus,smoking,and the risk for asymptomatic peripheral arterial disease:whom should we screen?[J].J Am Borad Fam Pract,2005,18:355.
  • 10Creager MA,Luscher TF.Diabetes and vascular disease pathophysiology,clinical consequences and medical therapy:Part Ⅰ[J].Circulation,2003,108:1527.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部